352
Views
8
CrossRef citations to date
0
Altmetric
Drug Evaluation

Eribulin in non-small cell lung cancer: challenges and potential strategies

, &
Pages 495-508 | Received 15 Sep 2016, Accepted 03 Feb 2017, Published online: 22 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marco Tagliamento, Carlo Genova, Giovanni Rossi, Simona Coco, Erika Rijavec, Maria Giovanna Dal Bello, Simona Boccardo, Francesco Grossi & Angela Alama. (2019) Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. Expert Opinion on Investigational Drugs 28:6, pages 513-523.
Read now

Articles from other publishers (7)

Siraprapa Saetan, Wanida Sukketsiri, Pennapa Chonpathompikunlert, Wanwimol Klaypradit, Mantira Hawangjoo, Nujamee Ngasakul & Supita Tanasawet. (2023) Antiproliferative and apoptotic effect of tuna blood on human lung cancer A549 cells via p38 MAPKs and Akt pathway. Journal of King Saud University - Science 35:5, pages 102667.
Crossref
Tania B. Lopez-Mendez, Raffaele Strippoli, Flavia Trionfetti, Pilar Calvo, Marco Cordani & Juan Gonzalez-Valdivieso. 2023. Cancer Nanotechnology. Cancer Nanotechnology 325 383 .
Priyanka Sekar, Raashmi Ravitchandirane, Sofia Khanam, Nethaji Muniraj & Ananda Vayaravel Cassinadane. (2022) Novel molecules as the emerging trends in cancer treatment: an update. Medical Oncology 39:2.
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 507 546 .
Mei-chen Wan, Wen Qin, Chen Lei, Qi-hong Li, Meng Meng, Ming Fang, Wen Song, Ji-hua Chen, Franklin Tay & Li-na Niu. (2021) Biomaterials from the sea: Future building blocks for biomedical applications. Bioactive Materials 6:12, pages 4255-4285.
Crossref
Trista K. Hinz, Roshni Kalkur, Jonathan Rabinovitch, Wyatt Hinkle & Lynn E. Heasley. (2021) TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin. Molecular Pharmacology 100:2, pages 144-154.
Crossref
Jixian Liu, Xinhuang Yao, Da Wu, Yiwang Ye, Qiang Wu, Suyue Liu & Hao Wu. (2017) Effect of TW37 on the growth of H1975 EGFR‑TKI‑resistant lung cancer cells and its underlying mechanisms. Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.